63 related articles for article (PubMed ID: 24988974)
1. [Naltrexone implant treatment of polydrug dependence].
Krupitskiĭ EM; Blokhina EA; Verbitskaia EV; Mamontova OV; Zvartau EE; Tiikhonen Ia
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5 Pt 2):39-45. PubMed ID: 24988974
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Tiihonen J; Krupitsky E; Verbitskaya E; Blokhina E; Mamontova O; Föhr J; Tuomola P; Kuoppasalmi K; Kiviniemi V; Zwartau E
Am J Psychiatry; 2012 May; 169(5):531-6. PubMed ID: 22764364
[TBL] [Abstract][Full Text] [Related]
3. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
4. [Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach].
Krupitsky ЕМ; Kibitov АО; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Kosten Т; Nielsen D; Zvartau EE; Woody D
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4 Pt 2):14-23. PubMed ID: 26288297
[TBL] [Abstract][Full Text] [Related]
5. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
Krupitsky EM; Blokhina EA; Zvartau EE; Verbitskaya VE; Bushara EM; Tiurina AA; Palatkin VY; Yaroslavtseva TS; Burakov AM; Masalov DV; Romanova TN; Grininko AY; Sinha R; Kosten T
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):39-46. PubMed ID: 26525620
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Jayaram-Lindström N; Hammarberg A; Beck O; Franck J
Am J Psychiatry; 2008 Nov; 165(11):1442-8. PubMed ID: 18765480
[TBL] [Abstract][Full Text] [Related]
7. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
[TBL] [Abstract][Full Text] [Related]
8. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
12. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
15. Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.
Krupitsky E; Zvartau E; Blokhina E; Verbitskaya E; Wahlgren V; Tsoy-Podosenin M; Bushara N; Burakov A; Masalov D; Romanova T; Tyurina A; Palatkin V; Yaroslavtseva T; Pecoraro A; Woody G
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):614-620. PubMed ID: 27436632
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
[TBL] [Abstract][Full Text] [Related]
17. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
Ling W; Casadonte P; Bigelow G; Kampman KM; Patkar A; Bailey GL; Rosenthal RN; Beebe KL
JAMA; 2010 Oct; 304(14):1576-83. PubMed ID: 20940383
[TBL] [Abstract][Full Text] [Related]
19. A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence.
Rea F; Bell JR; Young MR; Mattick RP
Drug Alcohol Depend; 2004 Jul; 75(1):79-88. PubMed ID: 15225891
[TBL] [Abstract][Full Text] [Related]
20. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
